For more than 20 years, researchers have been studying TMS as a potential therapy for a number of neurological and psychiatric conditions. The U.S. Food and Drug Administration (FDA) has cleared the use of TMS for the treatment of depression in adults who haven’t been helped by medication. The use of TMS for autism is an emerging area of research.
Free certificates of participation are available upon successful completion of a brief knowledge quiz HERE
Want to learn more? Dr. Lindsay Oberman’s March 2018 presentation on TMS is available online HERE
Published: 12/05/2018
Dr. Casanova completed his residency training in neurology and then spent 3 years doing a fellowship in neuropathology at The Johns Hopkins Hospital. During his stay at the Johns Hopkins Hospital, Dr. Casanova was in-charge of Pediatric Neuropathology. He spent several years as Deputy Medical Examiner for Washington, D.C., where he gained valuable experience in the post-mortem examination of Sudden Infant Death Syndrome and child abuse. His expertise in the field was recognized by honorary appointments as a Scientific Expert for the Armed Forces Institute of Pathology and as a Professorial Lecturer for the Department of Forensic Science at George Washington University. Dr. Casanova spent 8 years helping to establish 2 of the most successful brain banks in this country: The Johns Hopkins Brain Resource Center (3 years) and the Brain Bank Unit of the Clinical Brains Disorders Branch at the National Institutes of Mental Health (5 years). Dr. Casanova is well published in a multitude of postmortem techniques including neuronal morphometry, immunocytochemistry, neurochemistry, and autoradiography. Dr. Casanova has had over twenty years of experience in the neurosciences. Although trained in the classical methods of neurology and neuropathology, his interest has gradually shifted towards the study of abnormalities of cortical circuitry. His research has focused on the cell minicolumn, a vertical unit of 80 to 100 neurons having a common latency of response to stimulation. Using computerized imaging analysis he has established the anatomical validity of the cell minicolumn. His earlier work has reported interhemispheric differences in the morphometry of minicolumns that could provide for the speciation of hominids. His most recent studies have investigated the presence of abnormalities of minicolumnar organization and lateralization in the brains of patients who exhibit language disturbances, including autism, Asperger’s syndrome, and dyslexia. He is internationally known for his work in autism.
Improving Clinical Understanding of Autism
James McPartland, Ph.D., discusses current limitations in autism diagnosis and treatment, noting their reliance on behavioral observations despite the condition's genetic and neurological underpinnings. He advocates integrating biomarkers as objective, measurable biological
Editorial- Autism and the brain: the vital contribution of postmortem research
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects approximately 1% of the global population. It presents in diverse ways, but the core features typically include challenges with social
White Matter Development and Language in Autism
Tyler McFayden, Ph.D., considers the intersection of white matter development and language in autism. She discusses language modality and considers how white matter may help predict autism diagnosis and inform interventions.
Behavioral and Brain Signatures of Autism in Females
Kaustubh Supekar, Ph.D., examines recent findings about gender/sex differences in autism phenotypes and brain organization. He highlights the underrepresentation of females in autism and underscores the need for a large-scale science approach. The
Overview: Medical Comorbidities and ASD
In this brief overview, neurologist Margaret Bauman, MD summarizes symptoms and signs of medical comorbidities that frequently occur, but may go unrecognized, in patients diagnosed with ASD. While the underlying cause of autism
Brain Tissue Bank – Research Brings Hope
Tune in as David Amaral, Ph.D., presents on advances in brain tissue donation and research. This presentation is on YouTube and can be shared on social media, via email, on websites, etc.